Table 5.
Best subset of variables with the strongest predictive value for the incidence of posttransplant CMV infection according to the multivariate analysis.
| Best Subset of Parameters | Multivariate Analysis | ||
|---|---|---|---|
| OR | 95% CI | p | |
| Lack of KIR2DS2 | 7.984 | 1.155–55.215 | 0.04 |
| KIR2DL2-HLA-C1 | 8.197 | 1.055–62.500 | 0.04 |
| KIR2DL3 | 4.219 | 0.866–20.833 | 0.08 |
| Allograft dysfunction | 1.030 | 1.002–1.059 | 0.04 |
| Lymphocytopenia | 3.200 | 1.286–7.960 | 0.01 |
| Earlier time of antiviral prophylaxis initiation | 1.107 | 1.013–1.212 | 0.03 |
| D+/R− pretransplant serostatus | 3.241 | 1.043–10.069 | 0.04 |
KIR, killer-cell immunoglobulin-like receptor; CI, confidence interval; OR, odds ratio; D, donor; R, recipient.